Fachthema

Cutaneous T-cell lymphoma

Mogamulizumab superior to vorinostat for previously treated CTCL

Jatros Digital, 28.11.2017
Onkologie | Hämatologie

Youn H. Kim, MD, of Stanford University, talking about the results from the phase-III-study MAVORIC.